There is a rich literature discussing the involvement of TNF and other inflammatory cytokines in behaviors such as anxiety and depression [48,49], and evidence from clinical trials using anti-TNF biologic therapies for psoriasis and rheumatoid arthritis patients demonstrated that treatment caused significant changes in mood [13,50]. This evidence concerns the gene TNF and depressive symptom measurement.